BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25905808)

  • 1. Gene length matters in neurons.
    Zylka MJ; Simon JM; Philpot BD
    Neuron; 2015 Apr; 86(2):353-5. PubMed ID: 25905808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes.
    Boxer LD; Renthal W; Greben AW; Whitwam T; Silberfeld A; Stroud H; Li E; Yang MG; Kinde B; Griffith EC; Bonev B; Greenberg ME
    Mol Cell; 2020 Jan; 77(2):294-309.e9. PubMed ID: 31784358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics. Exceptional epigenetics in the brain.
    Luo C; Ecker JR
    Science; 2015 Jun; 348(6239):1094-5. PubMed ID: 26045424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal non-CG methylation is an essential target for MeCP2 function.
    Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
    Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.
    Yasui DH; Peddada S; Bieda MC; Vallero RO; Hogart A; Nagarajan RP; Thatcher KN; Farnham PJ; Lasalle JM
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19416-21. PubMed ID: 18042715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized.
    Bienvenu T; Chelly J
    Nat Rev Genet; 2006 Jun; 7(6):415-26. PubMed ID: 16708070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-specific DNA binding by AT-hook motifs in MeCP2.
    Lyst MJ; Connelly J; Merusi C; Bird A
    FEBS Lett; 2016 Sep; 590(17):2927-33. PubMed ID: 27461740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MECP2, a multi-talented modulator of chromatin architecture.
    Della Ragione F; Vacca M; Fioriniello S; Pepe G; D'Esposito M
    Brief Funct Genomics; 2016 Nov; 15(6):420-431. PubMed ID: 27296483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of Rett syndrome causing gene MECP2--the structure, function and modulation of MECP2].
    Zhang JJ; Bao XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):712-5. PubMed ID: 20019788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epigenome: what we learned from Rett syndrome, a neurological disease caused by mutation of a methyl-CpG binding protein].
    Kubota T
    Rinsho Shinkeigaku; 2013; 53(11):1339-41. PubMed ID: 24291980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mecp2-null mice provide new neuronal targets for Rett syndrome.
    Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
    PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 binding to DNA depends upon hydration at methyl-CpG.
    Ho KL; McNae IW; Schmiedeberg L; Klose RJ; Bird AP; Walkinshaw MD
    Mol Cell; 2008 Feb; 29(4):525-31. PubMed ID: 18313390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteins.
    Gartler SM; Varadarajan KR; Luo P; Canfield TK; Traynor J; Francke U; Hansen RS
    BMC Biol; 2004 Sep; 2():21. PubMed ID: 15377381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2 in central nervous system glial cells: current updates.
    Sharma K; Singh J; Frost EE; Pillai PP
    Acta Neurobiol Exp (Wars); 2018; 78(1):30-40. PubMed ID: 29694339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.